Version 1.0 — Published April 2026
Quick Answer
Ascending cholangitis is acute bacterial infection of the biliary tree, usually from choledocholithiasis causing obstruction above which gut bacteria proliferate. In a 62-year-old woman with fever, RUQ pain, jaundice, hypotension (BP 88/54), tachycardia (HR 118), and altered sensorium — Reynolds pentad is complete. Follow this 5-step workflow:
- Recognize severity — Reynolds pentad plus organ dysfunction (altered mental status, hypotension) meets TG18 Grade III severe cholangitis
- Resuscitate aggressively — crystalloid bolus 30 mL/kg within 3 hours, norepinephrine for MAP below 65 after fluids, target lactate clearance above 10 percent at 2 hours
- Start empiric antibiotics within 1 hour — piperacillin-tazobactam 4.5 g IV every 6-8 hours OR meropenem 1 g IV every 8 hours; add metronidazole if using ceftriaxone
- Confirm diagnosis with imaging — abdominal ultrasound first (biliary dilatation 70-95 percent sensitive for CBD stones >= 5 mm); MRCP or EUS if USG inconclusive
- Urgent biliary drainage within 12-24 hours — ERCP with stone extraction and stenting is first-line; PTBD if ERCP unavailable; surgical CBD exploration only if both fail
The case
A 62-year-old homemaker is brought to the emergency department by her son at 11 PM with a 2-day history of fever with chills, progressive yellowing of the eyes, and right upper quadrant abdominal pain. Over the past 6 hours, her family noticed she has become drowsy, confused about the day and her surroundings, and stopped responding to questions with full sentences.
She has a 4-year history of symptomatic gallstone disease (ultrasound-confirmed cholelithiasis, with three prior episodes of biliary colic), has repeatedly declined elective cholecystectomy citing fear of surgery, and is otherwise well. She has type 2 diabetes (on metformin 500 mg twice daily, HbA1c 7.8 percent last checked 2 months ago) and hypertension (on amlodipine 5 mg daily). No history of recent ERCP or biliary intervention. No alcohol use. No travel history.
On arrival, her vitals are: pulse 118 bpm regular, BP 88/54 mmHg, respiratory rate 24/min, SpO2 94 percent on room air, temperature 39.2 C (102.6 F). She opens her eyes to voice but is oriented only to person (Glasgow Coma Scale E3V4M6 = 13). Capillary refill 4 seconds. She appears toxic and visibly jaundiced, with warm peripheries despite hypotension.
History and examination
Acute cholangitis is the immediate clinical anchor in any patient with fever, jaundice, and RUQ pain — Charcot's triad. When hypotension and altered sensorium are added, the full Reynolds pentad signals severe suppurative cholangitis with septic shock, carrying a mortality of 20-50 percent without urgent biliary drainage (Tokyo Guidelines 2018). In India, gallstone disease prevalence is 4-11 percent with a strong female predominance (ICMR, 2021), and choledocholithiasis (stones in the common bile duct) is the commonest cause of community-acquired cholangitis at 80-90 percent of cases.
Abdominal examination:
- Mild distension, no visible peristalsis
- Tender hepatomegaly — liver edge 3 cm below the right costal margin, soft, smooth, tender
- Marked tenderness in the right upper quadrant with voluntary guarding
- Murphy's sign negative (no inspiratory arrest on RUQ palpation)
- No palpable gallbladder (Courvoisier's law — a palpable gallbladder with jaundice suggests malignant distal obstruction, not stone disease)
- Bowel sounds sluggish
- No shifting dullness (no clinical ascites)
Cardiovascular examination:
- Pulse: 118 bpm, regular, low volume
- JVP: not elevated
- Heart sounds: S1 and S2 normal, no murmurs
- Warm peripheries despite hypotension (distributive/septic shock pattern)
- Capillary refill delayed at 4 seconds
Respiratory examination:
- Tachypnea (rate 24/min) with no added sounds
- SpO2 94 percent on room air (mild hypoxia from sepsis)
Neurological examination:
- GCS 13 (E3V4M6) — altered sensorium consistent with septic encephalopathy or hepatic component
- Pupils equal and reactive, no focal deficit
- No neck stiffness
Integument:
- Marked scleral icterus and generalized skin jaundice
- No spider nevi, no palmar erythema (argues against chronic liver disease)
- No petechiae or ecchymoses (early DIC screen still needed)
Differential diagnosis
Acute ascending cholangitis is the leading diagnosis, but the differential for fever plus jaundice plus RUQ pain in an elderly diabetic is broad. The top 6 conditions to rule in or rule out:
| Diagnosis | Points in favor | Points against |
|---|
| Acute ascending cholangitis | Reynolds pentad complete, known gallstones, tender hepatomegaly, leukocytosis, direct hyperbilirubinemia with raised ALP | None — all findings consistent |
| Acute cholecystitis | RUQ pain, fever, gallstone history | Murphy's sign negative, no gallbladder wall thickening expected, jaundice uncommon unless Mirizzi syndrome (stone compressing CBD) |
| Liver abscess (pyogenic or amebic) | Fever, RUQ pain, tender hepatomegaly, leukocytosis | No recent travel, no dysentery history, imaging typically shows single/multiple liver cavities; jaundice less pronounced |
| Viral hepatitis (severe) | Jaundice, altered sensorium (hepatic encephalopathy) | Transaminases typically 1000s (hepatocellular pattern), ALP only mildly raised, no RUQ tenderness to this degree |
| Cholangiocarcinoma with infection | Painless jaundice with infection superimposed, elderly | Classically painless jaundice, palpable non-tender gallbladder (Courvoisier), needs imaging (mass lesion) |
| Acute pancreatitis (gallstone) | Gallstone history, possible jaundice if CBD obstruction | Epigastric pain radiating to back would dominate, lipase elevation expected |
| Septic shock from non-biliary source | Hypotension, altered sensorium, leukocytosis | Direct hyperbilirubinemia with raised ALP strongly points to biliary sepsis |
The combination of Reynolds pentad (fever, RUQ pain, jaundice, hypotension, altered sensorium) plus direct hyperbilirubinemia with raised ALP in a patient with known gallstones clinches the diagnosis: acute ascending cholangitis, TG18 Grade III (severe), almost certainly from choledocholithiasis causing CBD obstruction.
Investigations
Laboratory workup is performed immediately alongside resuscitation — results from this patient:
- CBC: Hb 11.8 g/dL, WBC 19,400/mm3 with 88 percent neutrophils and band forms (left shift), platelets 118,000/mm3 (mild thrombocytopenia — early DIC concern)
- Liver function tests: Total bilirubin 6.4 mg/dL with direct fraction 4.9 mg/dL (cholestatic pattern), ALP 480 U/L (3x ULN), GGT 310 U/L (raised), AST 120 U/L, ALT 96 U/L (mild transaminitis — disproportionate ALP/GGT elevation confirms cholestatic over hepatocellular)
- Coagulation: INR 1.7, prothrombin time 19 seconds (prolonged — from sepsis-associated coagulopathy or reduced vitamin-K-dependent synthesis)
- Renal panel: Creatinine 1.9 mg/dL (raised from baseline 0.9), urea 62 mg/dL, Na 132, K 4.0 — acute kidney injury stage 2
- Arterial blood gas: pH 7.28, HCO3 16, lactate 4.8 mmol/L (metabolic acidosis with raised lactate — confirms tissue hypoperfusion)
- Blood glucose: 246 mg/dL (stress hyperglycemia with background diabetes)
- Blood cultures: two sets drawn before antibiotics
- Lipase: 98 U/L (within normal limits — excludes coexisting pancreatitis)
- Procalcitonin: 18 ng/mL (markedly elevated — supports bacterial sepsis)
- CRP: 220 mg/L
Imaging:
- Bedside abdominal ultrasound (first-line): dilated common bile duct (CBD 12 mm, normal <= 6 mm), hyperechoic shadow within the distal CBD suggestive of stone, multiple gallstones in the gallbladder (wall thickness 3 mm, not thickened), no pericholecystic fluid, mild hepatomegaly with normal parenchyma, no ascites
- CT abdomen with contrast (to exclude other sepsis source and assess severity): confirms dilated intra- and extrahepatic biliary tree, distal CBD calculus 9 mm, patchy hepatic enhancement suggestive of cholangitic inflammation, no liver abscess, no pancreatic inflammation
These findings — dilated CBD (above 6 mm), distal CBD stone, and cholestatic LFT pattern — establish the etiology as choledocholithiasis-induced ascending cholangitis.
Diagnosis
Acute ascending cholangitis secondary to choledocholithiasis — Tokyo Guidelines 2018 Grade III (severe) in a 62-year-old diabetic woman, with:
- Complete Reynolds pentad (fever, RUQ pain, jaundice, hypotension, altered mental status)
- Multi-organ dysfunction: cardiovascular (hypotension despite fluids), neurological (altered sensorium GCS 13), renal (AKI stage 2), hematologic (thrombocytopenia with INR 1.7 — early DIC)
- Septic shock with lactate 4.8 mmol/L
TG18 diagnostic verification
Domain A — systemic inflammation: fever 39.2 C, WBC 19,400/mm3, CRP 220 mg/L — POSITIVE.
Domain B — cholestasis: total bilirubin 6.4 mg/dL, ALP 480 U/L (above 1.5x ULN) — POSITIVE.
Domain C — imaging: CBD dilatation 12 mm with distal CBD stone — POSITIVE.
Definite diagnosis requires positivity in all three domains — satisfied.
TG18 severity grading
Grade III criteria — any one organ dysfunction:
| Organ system | Criterion | Present? |
|---|
| Cardiovascular | Hypotension needing vasopressor | Yes (anticipating) |
| Neurological | Altered mental status | Yes (GCS 13) |
| Respiratory | PaO2/FiO2 < 300 | Borderline (94 percent SpO2 on RA) |
| Renal | Creatinine > 2 mg/dL or oliguria | Near-threshold (1.9 mg/dL, rising) |
| Hepatic | INR > 1.5 | Yes (1.7) |
| Hematologic | Platelets < 100,000 | Near-threshold (118,000) |
Two definitive organ dysfunctions (neurological, hepatic) confirm Grade III severe cholangitis — this patient requires ICU admission, aggressive resuscitation, and biliary drainage within 12-24 hours.
Management
Severe ascending cholangitis management follows four simultaneous streams — they are not sequential. NEET PG tests the parallel protocol, not a drug-by-drug list.
Stream 1: Resuscitation (first hour — concurrent with stream 2)
- Two large-bore IV lines (16G), send blood cultures (before antibiotics but must not delay them).
- Crystalloid bolus 30 mL/kg of Ringer's lactate or Plasmalyte within the first 3 hours. Balanced crystalloids preferred over 0.9 percent saline (BaSICS and PLUS trials, NEJM 2021).
- Central venous access and arterial line for continuous monitoring if Grade III.
- Norepinephrine starting at 0.05 microgram/kg/min if MAP stays below 65 after the 30 mL/kg bolus — this is the first-line vasopressor per Surviving Sepsis Campaign 2021.
- Target MAP above 65 mmHg, urine output 0.5 mL/kg/hour, lactate clearance above 10 percent at 2 hours.
- Supplemental oxygen to maintain SpO2 above 94 percent; consider HFNC or mechanical ventilation if respiratory failure evolves.
- ICU admission for all Grade III patients.
Stream 2: Antibiotics (within 1 hour of recognition — concurrent with stream 1)
Each hour of antibiotic delay increases mortality by 7.6 percent in septic shock (Kumar et al., Crit Care Med, 2006). Do NOT wait for cultures.
| Scenario | Preferred regimen | Rationale |
|---|
| Community-acquired, moderate severity | Ceftriaxone 2 g IV OD + metronidazole 500 mg IV q8h | Cephalosporins need anaerobic cover |
| Community-acquired, severe (Grade III) | Piperacillin-tazobactam 4.5 g IV q6-8h | Single-agent cover of most biliary pathogens including anaerobes |
| Healthcare-associated or prior ERCP | Meropenem 1 g IV q8h or imipenem 500 mg IV q6h | ESBL and resistant organism coverage |
| Penicillin-anaphylaxis | Ciprofloxacin 400 mg IV q12h + metronidazole 500 mg IV q8h | Avoids beta-lactams |
Common pathogens: E. coli (25-50 percent), Klebsiella (15-20 percent), Enterococcus (10-20 percent), Enterobacter, Bacteroides. Narrow antibiotics after culture results. Duration: 4-7 days AFTER adequate source control (biliary drainage). In this patient with septic shock and suspected community-acquired biliary sepsis, piperacillin-tazobactam 4.5 g IV every 6 hours is started immediately.
Stream 3: Biliary drainage (within 12-24 hours for Grade III)
Source control is the definitive therapy. Antibiotics alone cannot resolve an obstructed biliary system containing pus under pressure.
| Modality | Indication | Success rate | Comments |
|---|
| ERCP with sphincterotomy + stone extraction ± stent | First-line; 90-95 percent success for choledocholithiasis | 90-95 percent | Minimally invasive, same-session diagnosis and treatment |
| Percutaneous transhepatic biliary drainage (PTBD) | ERCP unavailable/failed, altered anatomy (Roux-en-Y), hilar strictures | 85-90 percent | More invasive; risk of bleeding, bile leak |
| Surgical common bile duct exploration with T-tube | Last-line; both ERCP and PTBD failed, or unstable for endoscopy | 70-85 percent | High morbidity in septic patient; avoided if possible |
For this patient with Grade III cholangitis and septic shock, plan is: stabilize hemodynamically over 2-4 hours in ICU, then urgent ERCP within 12-24 hours with sphincterotomy, stone extraction, and biliary stent if edema/inflammation is severe. The 2018 Tokyo Guidelines stress that urgent drainage should NOT be delayed while waiting for lab normalization — coagulopathy and thrombocytopenia are relative, not absolute, contraindications to ERCP in severe sepsis.
Explore more surgery high-yield topics and see the related elderly jaundice clinical case on cholangiocarcinoma to contrast obstructive jaundice patterns.
Stream 4: Supportive care and interval cholecystectomy
- Glycemic control: insulin infusion to maintain glucose 140-180 mg/dL (avoid tight control below 110 — NICE-SUGAR trial, NEJM 2009).
- Vitamin K 10 mg IV to correct cholestasis-associated coagulopathy.
- Nutritional support once hemodynamics stabilize — early enteral nutrition within 48 hours reduces infectious complications.
- DVT prophylaxis with mechanical compression first; pharmacologic prophylaxis once INR below 1.5 and platelets above 100,000.
- Interval laparoscopic cholecystectomy within 6-8 weeks of recovery (or during same admission if clinically stable after drainage) — leaving the gallbladder behind after ERCP has a 20-30 percent recurrence rate of biliary events within 2 years.
How NEET PG tests ascending cholangitis
Ascending cholangitis appears in 1-2 NEET PG questions per paper in the surgery or medicine section, tested through four dominant patterns:
Pattern 1 — The triad/pentad recognition question: A vignette gives fever, RUQ pain, jaundice, with or without hypotension and altered sensorium. You must name Charcot's triad (3 features) or Reynolds pentad (5 features, implies severe suppurative cholangitis). The trap: choosing acute cholecystitis (RUQ pain and fever but typically no jaundice; Murphy's sign positive).
Pattern 2 — The TG18 severity grading question: Given clinical and lab data, classify as Grade I, II, or III. A Grade III diagnosis mandates ICU admission and ERCP within 12-24 hours. Memorize the 6 organ dysfunctions that define Grade III.
Pattern 3 — The antibiotic choice question: Which empiric regimen covers the expected biliary pathogens? First-line single-agent = piperacillin-tazobactam. With ceftriaxone, always ADD metronidazole for anaerobic cover. Carbapenem for severe or healthcare-associated cases.
Pattern 4 — The ERCP timing question: When should ERCP be performed? Grade III = within 12-24 hours (urgent). Grade II = within 24-48 hours (early). Grade I = elective within 72 hours or same admission. The commonest wrong answer is "immediate ERCP before resuscitation" — stabilize first, then drain.
High-yield one-liners for last-day revision:
- Charcot's triad = fever + RUQ pain + jaundice (sensitivity 26 percent — LOW)
- Reynolds pentad = triad + hypotension + altered mental status (specificity high, mandates urgent drainage)
- TG18 definite diagnosis requires positivity in all three domains (A + B + C)
- Grade III cholangitis = any organ dysfunction → urgent ERCP within 12-24 hours
- Commonest organism = E. coli (25-50 percent of cases)
- First-line empiric antibiotic = piperacillin-tazobactam OR carbapenem for severe
- Ceftriaxone always needs metronidazole added (cephalosporins lack anaerobic cover)
- Courvoisier's law: palpable non-tender gallbladder with jaundice suggests malignant distal obstruction, NOT stones
- Interval cholecystectomy within 6-8 weeks of recovery to prevent recurrence
Frequently asked questions
What is the difference between Charcot's triad and Reynolds pentad in cholangitis?
Charcot's triad is fever, right upper quadrant (RUQ) pain, and jaundice — present in 50-70 percent of acute cholangitis cases. Reynolds pentad adds two more features: hypotension (septic shock) and altered mental status. Reynolds pentad indicates suppurative cholangitis with severe sepsis and carries a mortality of 20-50 percent without urgent biliary drainage. The pentad is found in only 5-10 percent of cholangitis cases but mandates immediate ICU-level resuscitation plus ERCP within 24 hours. The absence of Charcot's triad does NOT exclude cholangitis — Tokyo Guidelines 2018 shifted to a 3-domain diagnostic framework (systemic inflammation, cholestasis, imaging) because the triad sensitivity is only 26 percent.
What are the Tokyo Guidelines 2018 criteria for diagnosing acute cholangitis?
TG18 uses three diagnostic domains. A — systemic inflammation: fever above 38 C or evidence of inflammatory response (WBC abnormal, CRP raised). B — cholestasis: jaundice (total bilirubin 2 mg/dL or above) or abnormal liver function (ALP, GGT, AST, ALT above 1.5x ULN). C — imaging: biliary dilatation or evidence of etiology (stone, stricture, stent). Suspected diagnosis requires 1 item from A plus 1 item from B or C. Definite diagnosis requires 1 item from all three domains (A + B + C). TG18 replaced Charcot's triad as the primary diagnostic framework because of low triad sensitivity.
How is cholangitis severity graded by Tokyo Guidelines 2018?
TG18 grades severity in three tiers. Grade III (severe) — presence of any one organ dysfunction: cardiovascular (hypotension needing dopamine 5 microgram/kg/min or above, or any norepinephrine), neurological (altered mental status), respiratory (PaO2/FiO2 below 300), renal (creatinine above 2 mg/dL or oliguria), hepatic (INR above 1.5), or hematologic (platelets below 100,000). Grade II (moderate) — any two of: WBC above 12,000 or below 4,000, fever above 39 C, age 75 or above, hyperbilirubinemia (above 5 mg/dL), hypoalbuminemia (below 0.7x normal). Grade I (mild) — neither Grade II nor III criteria. Grade III requires urgent (within 12-24 hours) biliary drainage and ICU care.
Which antibiotics are preferred for acute cholangitis?
Initial empiric therapy must cover gram-negative enteric organisms (E. coli 25-50 percent, Klebsiella 15-20 percent, Enterobacter) and anaerobes if history of biliary intervention. Preferred regimens: piperacillin-tazobactam 4.5 g IV every 6-8 hours (covers most community-acquired biliary pathogens), or a carbapenem (meropenem 1 g IV every 8 hours, imipenem 500 mg IV every 6 hours) for severe grade III infection or healthcare-associated cases. Add metronidazole 500 mg IV every 8 hours if using a third-generation cephalosporin (ceftriaxone) because cephalosporins have poor anaerobic coverage. Narrow antibiotics after bile or blood culture results (bile culture positive in 60-90 percent of cases). Duration is 4-7 days after adequate source control.
When should ERCP be performed in acute cholangitis?
ERCP timing is driven by TG18 severity. Grade III (severe): urgent biliary drainage within 12-24 hours after initial resuscitation — delay increases mortality by 30 percent for every 24 hours. Grade II (moderate): early ERCP within 24-48 hours once the patient is stabilized. Grade I (mild): elective ERCP within 72 hours if antibiotics fail to produce clinical improvement (or during the same admission). ERCP achieves biliary drainage through stone extraction, sphincterotomy, or stent placement. In unstable patients unable to tolerate ERCP, percutaneous transhepatic biliary drainage (PTBD) is the alternative. Surgical drainage (open common bile duct exploration) is reserved for ERCP and PTBD failure.
How do I choose between ERCP, PTBD, and surgical drainage in cholangitis?
ERCP is first-line in most cases — it is less invasive, has lower morbidity (3-7 percent vs 10-15 percent for PTBD), and addresses the cause (stone extraction, stent placement across stricture). ERCP success rate is 90-95 percent for choledocholithiasis. PTBD is preferred when ERCP is unavailable or fails, or when there is altered post-surgical anatomy (Roux-en-Y, prior gastric bypass). PTBD is also useful for hilar strictures. Surgical drainage (T-tube placement after common bile duct exploration) is now rarely first-line but is indicated when endoscopic and percutaneous approaches both fail, or when definitive surgery is already planned for the underlying pathology (e.g., bile duct tumor).
What fluid resuscitation targets apply in septic cholangitis?
Follow Surviving Sepsis Campaign 2021 guidelines. Initial crystalloid bolus 30 mL/kg within the first 3 hours (balanced crystalloid such as Ringer's lactate preferred over normal saline — the BaSICS and PLUS trials show less hyperchloremic acidosis). Target mean arterial pressure (MAP) above 65 mmHg. If MAP remains below 65 after fluid resuscitation, start norepinephrine as the first-line vasopressor. Monitor lactate clearance — goal is above 10 percent reduction within the first 2 hours. Urine output target is 0.5 mL/kg/hour. Simultaneous broad-spectrum antibiotics should be given within 1 hour of recognition — each hour of delay increases mortality by 7.6 percent (Kumar et al., Crit Care Med, 2006).
How is ascending cholangitis tested in NEET PG?
NBE tests cholangitis through four patterns: recognition of Charcot's triad vs Reynolds pentad (with Reynolds pentad mandating urgent drainage), application of Tokyo Guidelines 2018 diagnosis and severity grading, choice of first-line antibiotic (piperacillin-tazobactam or carbapenem plus metronidazole if cephalosporin is used), and timing of ERCP based on severity (within 24 hours for grade III). Expect 1-2 cholangitis questions per NEET PG paper in the surgery or medicine section, often as a clinical vignette requiring integrated decision-making across diagnosis, resuscitation, and intervention timing.
This content is for educational purposes for NEET PG exam preparation. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical information has been reviewed by qualified medical professionals.
Sources and references
- Kiriyama S et al., "Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis," Journal of Hepato-Biliary-Pancreatic Sciences, 2018 — definitive guideline for cholangitis diagnosis and severity.
- Bailey and Love's Short Practice of Surgery, 28th Edition (Williams et al., 2022) — comprehensive chapter on biliary tract surgery including stone disease and cholangitis.
- Evans L et al., "Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021," Intensive Care Medicine, 2021 — fluid resuscitation and antibiotic timing protocol used in severe cholangitis.
Strengthen your biliary sepsis reasoning by working through resuscitation and drainage vignettes. Review the full surgery subject page, build out your elderly-jaundice clinical pattern recognition, and drill targeted hepatobiliary MCQs on the NEETPGAI practice platform. Ready for unlimited AI-powered MCQs with detailed explanations? Explore NEETPGAI Pro.
For personalized study guidance on surgery and gastroenterology, try the AI Tutor — it adapts to your weak areas and explains concepts the way a senior resident would.
Written by: NEETPGAI Editorial Team
Reviewed by: Pending SME Review
Last reviewed: April 2026
This article is reviewed by qualified medical professionals for clinical accuracy and exam relevance. For corrections or updates, contact the editorial team.
